西罗莫司涂层球囊血管成形术在无组织丧失的股腘动脉疾病中的应用：SirPAD试验的积极次要结局
Posted inCardiology Clinical Updates

Sirolimus-Coated Balloon Angioplasty in Femoropopliteal Artery Disease Without Tissue Loss: Promising Secondary Outcomes from the SirPAD Trial

This secondary analysis of the SirPAD trial shows that sirolimus-coated balloon angioplasty significantly reduces 1-year target-lesion revascularization rates compared to uncoated balloons in femoropopliteal artery disease patients without tissue loss, suggesting a safer and more effective treatment option.
Consistent Improvement in Walking Function Across Diabetes Profiles with Semaglutide in Peripheral Artery Disease: Lessons from the STRIDE Trial
Posted inClinical Updates Diabetes & Endocrinology news Specialties

Consistent Improvement in Walking Function Across Diabetes Profiles with Semaglutide in Peripheral Artery Disease: Lessons from the STRIDE Trial

The STRIDE trial demonstrates that once-weekly semaglutide significantly enhances walking capacity in patients with symptomatic peripheral artery disease and type 2 diabetes, irrespective of baseline diabetes duration, BMI, HbA1c levels, or diabetes medication use.